| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.2M | -86.5% |
| Cost of Revenue | $40.0M | -87.7% |
| Gross Profit | $6.2M | -64.7% |
| R&D Expense | $26.0M | -29.9% |
| SG&A Expense | $63.0M | -7.5% |
| Operating Income | -$130.0M | -21.8% |
| Pre-tax Income | -$135.7M | -37.4% |
| Income Tax | $67K | +119.2% |
| Net Income | -$135.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.1M | -75.4% |
| Short-term Investments | $2.9M | — |
| Accounts Receivable | $14.6M | -46.4% |
| Inventory | $107K | -74.2% |
| Current Assets | $68.9M | -75.4% |
| Total Assets | $183.9M | -46.0% |
| Current Liabilities | $54.7M | -51.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.9M | +39.7% |
| Capital Expenditures | $58.9M | +93.4% |
| Investing Cash Flow | -$58.7M | -38.1% |
| Financing Cash Flow | -$252K | +95.4% |
| Free Cash Flow | -$114.7M | +6.8% |
| -37.9% |
| EPS (Basic) | -$0.91 | -31.9% |
| EPS (Diluted) | -$0.91 | -31.9% |
| Total Liabilities |
| $57.6M |
| -50.7% |
| Stockholders' Equity | $126.3M | -43.6% |